the evolving treatment paradigm for braf v600e-mutant mcrc
Published 1 year ago • 259 plays • Length 2:28Download video MP4
Download video MP3
Similar videos
-
1:17
treatment approaches for braf v600e mutant metastatic colorectal cancer
-
1:24
fire-4.5: folfoxiri plus either bevacizumab or cetuximab as 1l treatment of braf v600e-mutant mcrc
-
1:45
breakwater: encorafenib plus cetuximab in patients with braf v600e-mutant mcrc
-
2:56
treating braf v600e-mutant nsclc with dabrafenib and trametinib
-
1:26
novel treatment strategies for braf v600e-mutant nsclc
-
2:31
how do braf-targeted therapies for melanoma work?
-
4:37
tafinlar® (dabrafenib) mekinist® (trametinib) mechanism of action for advanced melanoma
-
22:40
how to approach the patient with braf mutant tumor
-
52:55
optimizing testing and treatment of patients with brafv600e-mutant mcrc in community practice
-
1:55
dr. lieu on the predictive value of braf v600e mutations in crc
-
2:44
the rationale behind the addition of immuntherpay to tkis in treating brafv600e mutated mcrc
-
0:38
what’s next for patients with braf vj600e mutant metastatic crc?
-
0:33
cetuximab - erbitux - in a nutshell.
-
0:58
targeting wnt in braf-mutant colorectal cancer
-
2:37
evolving treatment paradigms in mrcc
-
1:09
dr. kopetz on updated data from beacon crc study in braf v600e–mutant crc
-
1:22
influence of sidedness on prognosis and treatment in mcrc
-
1:35:47
braf-mutated mcrc: from diagnosis to treatment
-
1:04
the future of targeted therapies for advanced colorectal cancer
-
1:16
enhancing metastatic pmmr colorectal cancer treatments
-
17:01
encorafenib, binimetinib, and cetuximab in braf v600e–mutated colorectal cancer
-
4:24
the current paradigm of metastatic colorectal cancer